Market Closed

BMRN
BioMarin Pharmaceutical
$ 57.23
0.93%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

BioMarin Pharmaceutical News

Latest BioMarin Pharmaceutical Stock News & BMRN Headlines

BioMarin Pharmaceutical Hits $1 Billion Revenue Milestone, Advances Rare-Disease Pipeline
3 days ago | marketbeat.com
BioMarin Pharmaceutical Inc. (BMRN) Presents at Stifel 2026 Healthcare Conference 2026 Transcript
3 days ago | seekingalpha.com
Traders Buy Large Volume of BioMarin Pharmaceutical Call Options (NASDAQ:BMRN)
10 days ago | defenseworld.net
BioMarin: Better Risk-Reward Ahead Of Three FDA Decisions
10 days ago | seekingalpha.com
BioMarin to Participate in Upcoming Investor Conferences
11 days ago | prnewswire.com
BioMarin Pharmaceutical Inc. (BMRN) Q3 2026 Earnings Call Transcript
12 days ago | seekingalpha.com
BioMarin Pharmaceutical Q3 Earnings Call Highlights
12 days ago | marketbeat.com
BioMarin (BMRN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
12 days ago | zacks.com
BioMarin Pharmaceutical (BMRN) Q3 Earnings Surpass Estimates
12 days ago | zacks.com
BioMarin Reports Third Quarter 2026 Financial and Operating Results
12 days ago | prnewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

BMRN
BioMarin Pharmaceutical
$ 57.23
0.93%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago